OTC · Financial Statements
Kintor Pharmaceutical Limited (KNTPF) Financial Statements
$0.23
OTC: KNTPF
Market Cap $107.85M
Overview Financials Dividend Kintor Pharmaceutical Limited most recently reported annual revenue of $32.0M, net profit of $-195.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $34.0M $0 $0 $5.0M $32.0M Operating Profit $-840.0M $-945.0M $-152.0M $-145.0M $-197.0M Net Profit $-842.0M $-954.0M $-1.1B $-155.0M $-195.0M EPS $-2.36 $-2.53 $-2.47 $-0.36 $-0.43 Op Margin -2452.8% — — -2891.4% -619.9%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $2.1B $2.1B $869.0M $515.0M $341.0M Total Liabilities $413.0M $560.0M $411.0M $221.0M $158.0M Cash $1.0M $1.0M $445.0M $147.0M $35.0M Borrowings $160.0M $286.0M $254.0M $133.0M $87.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-1.0M $-1.0M $-388.0M $-199.0M $-170.0M Investing Cash Flow $0 $0 $1.0M $18.0M $14.0M Financing Cash Flow $-888.0M $-820.0M $-5.0M $-5.0M $-1.0M Net Cash Flow $0 $0 $-420.0M $-297.0M $-115.0M Free Cash Flow $-1.0M $-1.0M $-390.0M $-201.0M $-170.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.27 EV / EBITDA -5.26 FCF Yield -25.50% Quick Ratio 0.34 Interest Coverage -52.00 Return 1Y 29.65% Return 3Y -49.04% Return 5Y —
Screens featuring this stock